Recently, two prominent ophthalmology practice groups — Kleiman Evangelista Eye Centers of Texas (KEEC) and SouthEast Eye Specialists, PLLC (SEES) — have reached substantial settlements with the U.S. government. The allegations were serious; it was claimed that these groups’ cataract arrangements violated vital healthcare laws, specifically, the Anti-Kickback Statute (AKS) and the False Claims Act (FCA).
Collectively, these settlements under the FCA culminated in payments nearing a staggering $20 million. This unexpectedly high figure reveals the serious nature of the alleged violations and sets a precedent for future similar cases. Notably, these cases provide insightful lessons for providers in ensuring they comply with the complex legal landscape of modern healthcare practices.
The allegations against the groups revolved around certain cataract surgery co-management arrangements. The AKS violation claims centered on assertions that optometrists were receiving payment from KEEC and SEES for post-op care, which was over and above fair market value. The FCA claims were related to accusations that the groups had begun filing fraudulent claims linked to cataract surgeries.
The repercussions of these infractions were both clear and impactful. A massive financial penalty is certainly significant, but perhaps the real impact lies in the reputational damage caused by such high-profile settlements. Firms should take note and re-assess their existing practices to avoid falling afoul of healthcare regulations. The long-term costs of non-compliance, both financial and reputational, are always significantly higher than the cost of staying within the boundaries of the law.
The webpage detailing the events can be accessed here. This case is an important reminder of the necessary adherence to legal standards, and indeed a clear example of the risks faced by medical practitioners and groups who don’t comply fully with regulations.